FRR-24162-62530
4 vaccinations
4 coded responses
13 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 531 / WI
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-27
Registered in v-safe
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Joint pains, Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
-
2020-12-30
Health check-in — day 7, dose 1Feeling: Good · Chills, Joint pains, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-01-06
Survey response — day 14, dose 1MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-20
Survey response — day 28, dose 1MedDRA: Chills, Fatigue, Gastric disorder, Headache, Injection site erythema, Injection site swelling, Lymph node pain, Lymphadenopathy, Nausea, Pyrexia — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: FatigueHeadache Nausea Gastric distressSwelling and redness at injection site.Swelling and pain in axillary lymph node of injection site arm. FeverChillsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
- 2021-02-03
- 2021-03-24
-
2021-06-23
Survey response — 6 months, dose 1MedDRA: Chills, Cough, Ear pain, Nasopharyngitis, Oropharyngeal pain, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold symptoms, fever, chills, cough, sore throat, ear pain, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-11-03
Dose 3 — Pfizer-BioNTech
- 2021-12-25
-
2022-11-01
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-11
Survey response — day 35, dose 4MedDRA: Abnormal uterine bleeding, Endometrial ablation, Headache, Menstrual disorder, Uterine dilation and curettage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Worsening/abnormal uterine bleeding during and outside of regular periods of menstration. Headaches. · Healthcare visit (other): D&C and AblationMedDRA releases: 2024-11 · check-in free text available
-
2022-12-11
Report sent to call center — day 35, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-12
- 2022-12-13
- 2023-01-31
- 2023-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | No |
| 3 | 2021-11-03 | Pfizer-BioNTech | No |
| 4 | 2022-11-01 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-06 | priority 2/3 | |
| 2022-12-11 | Unsuccessful |
Free text
Release 1 — day 14, dose 1
Symptoms: Fatigue
Release 2 — day 28, dose 1
Symptoms: FatigueHeadache Nausea Gastric distressSwelling and redness at injection site.Swelling and pain in axillary lymph node of injection site arm. FeverChills
Release 9 — 6 months, dose 1
Symptoms: Cold symptoms, fever, chills, cough, sore throat, ear pain, congestion
Release 12 — day 35, dose 4
Symptoms: Worsening/abnormal uterine bleeding during and outside of regular periods of menstration. Headaches.
Healthcare visit (other): D&C and Ablation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Endometrial ablation | · | · | ✓ |
| HCVO | Uterine dilation and curettage | · | · | ✓ |
| SD | Abnormal uterine bleeding | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Ear pain | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastric disorder | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Lymph node pain | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release